First patient included in AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440 – Marketscreener.com

First patient included in AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440 – Marketscreener.com
Source: Google NewsPublished on 2022-06-21